Updated:
EvoLabs
EvoLabs operates across seven global offices from Sunnyvale to Seoul, pursuing early-stage technology investments with a distributed venture studio model.
EvoLabs
EvoLabs sp. z o.o. — the Polish limited-liability designation — maintains operational presence in Sunnyvale, Singapore, London, Athens, Vienna, Indianapolis, and Seoul. The firm's cross-continental office map spans North America, Europe, and Asia, a geographic breadth uncommon for early-stage vehicles of its apparent size. The absence of a centralized headquarters or publicly named investment principals points toward a decentralized partnership or a corporate venture entity operating behind registered entities in multiple jurisdictions. The firm's investment strategy remains opaque in public filings. Its Polish incorporation, combined with offices in major technology hubs, suggests a focus on bridging Central European technical talent with Silicon Valley and Asian market access. Without disclosed portfolio companies or fund vehicles, the likely posture is that of a venture builder — forming, capitalizing, and operating companies internally — rather than a pooled fund manager raising external LP capital. No publicly reported close of a discrete fund vehicle exists in commercial registries. Team size and total deployment are not disclosed. The multi-office structure implies a network of local partners or venture partners rather than a consolidated investment committee. The Sunnyvale and Singapore presences align with traditional early-stage technology hubs, while Athens, Vienna, and Indianapolis may reflect operating company subsidiaries or R&D centers rather than investment offices. No known philanthropic foundations, club memberships, or parallel vehicles are associated with the EvoLabs entity. The structural differentiator is the firm's apparent choice to operate without a centralized public profile — no website, no named principals, no disclosed portfolio. This posture, combined with the Polish corporate form and global office footprint, suggests EvoLabs functions as a holding company or venture studio for a specific founder or family whose identity remains private. The entity may serve as the operational backbone for a series of technology startups rather than a third-party capital allocator.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Sunnyvale, Singapore, London, Athens, Vienna, Indianapolis, Seoul
Corporate office
—
Additional offices
Sunnyvale · Singapore · London · Athens · Vienna · Indianapolis · Seoul
Frequently asked questions
Who runs investment decisions at EvoLabs?
EvoLabs does not publicly name any principals, managing partners, or investment committee members. The firm's Polish registration and multi-office structure suggest decision-making is distributed across regional partners or centralized in an undisclosed parent entity. No individual has been publicly associated with the firm in a CIO or CEO capacity in commercial registries or media reports.
Is EvoLabs structured as a venture capital fund or a venture studio?
The firm's profile — no disclosed fund vehicles, no LP relationships, and offices in lower-cost operational hubs alongside major tech centers — aligns more closely with a venture studio or holding company model than a conventional VC fund raising external capital. The Polish 'sp. z o.o.' designation is a standard limited liability company form, not a fund structure.
Where does EvoLabs deploy capital?
EvoLabs' office footprint spans North America, Europe, and Asia, including key technology hubs like Sunnyvale, Singapore, London, and Seoul. This suggests deal activity or operational interests across multiple continents, though specific portfolio companies or investment geographies have not been publicly disclosed.
Does EvoLabs raise capital from outside LPs?
There is no public record of EvoLabs closing a fund or soliciting external limited partners. The firm appears to be self-capitalized or backed by a single undisclosed source, consistent with a family office, venture studio, or corporate venture entity that does not market to institutional allocators.
What is the significance of EvoLabs' Polish incorporation?
The 'sp. z o.o.' suffix indicates a Polish limited liability company, which may reflect the origin of the firm's founding principals or a deliberate choice of jurisdiction for operational or regulatory reasons. Combined with offices in Vienna and Athens, it suggests a Central and Eastern European nexus for the firm's administrative or technical operations.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: